A Population-based Investigation of the Autoantibody Profile in Mothers of Children with Atrioventricular Block

Scandinavian Journal of Immunology

Volumn 74, Issue 5, 2011, Pages 511-517

  Salomonsson, S ^a   Dzikaite, V ^a   Zeffer, E ^a   Eliasson, H ^a   Ambrosi, A ^a   Bergman, G ^a   Fernlund, E ^b   Theander, E ^b   Ohman A ^c   Rydberg, A ^d   Skogh, T ^e   Wallberg Jonsson S ^d   Elfving, A ^a   Fored, M ^a   Ekbom, A ^a   Lundstrom U ^f   Mellander, M ^f   Winqvist, O ^a   Sonesson, S E ^a   Gadler, F ^a   Jonzon, A ^c   Wahren Herlenius, M ^a   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CENP C ANTIBODY; EPITOPE; HISTONE ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; RIBOSOMAL RNP ANTIBODY; RNP 70 ANTIBODY; RNP A ANTIBODY; RNP C ANTIBODY; RO52 ANTIBODY; RO60 ANTIBODY; SCL 70 ANTIBODY; SMB ANTIBODY; SMD ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD SAMPLING; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY;

ADOLESCENT; ATRIOVENTRICULAR BLOCK; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHILD OF IMPAIRED PARENTS; CHILD, PRESCHOOL; EPITOPES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTHERS; POPULATION GROUPS; PREVALENCE; SWEDEN;

EID: 80053540936     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02610.x     Document Type: Article

References (32)

1. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:85-101.
2. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
3. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
4. Sonesson SE. Diagnosing foetal atrioventricular heart blocks. Scand J Immunol 2010;72:205-12.
5. Brucato A, Previtali E, Ramoni V, Ghidoni S. Arrhythmias presenting in neonatal lupus. Scand J Immunol 2010;72:198-204.
6. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995;92:442-9.
7. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004;50:1253-61.
8. Theander E, Brucato A, Gudmundsson S, Salomonsson S, Wahren-Herlenius M, Manthorpe R. Primary Sjogren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone. J Rheumatol 2001;28:373-6.
9. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999;42:2335-45.
10. Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol 2010;72:235-41.
11. Salomonsson S, Strandberg L. Autoantibodies associated with congenital heart block. Scand J Immunol 2010;72:185-8.
12. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001;44:647-52.
13. Julkunen H, Miettinen A, Walle TK, Chan EK, Eronen M. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. J Rheumatol 2004;31:183-9.
14. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-41.
15. Wahren-Herlenius M. Immunological contribution to the pathogenesis of congenital heart block. Scand J Immunol 2010;72:171-2.
16. Salomonsson S, Sonesson SE, Ottosson L et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005;201:11-7.
17. Wahren-Herlenius M, Sonesson SE. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006;18:690-6.
18. Strandberg L, Winqvist O, Sonesson SE et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008;154:30-7.
19. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004;50:173-82.
20. Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol 2010;72:189-97.
21. Villain E, Coastedoat-Chalumeau N, Marijon E, Boudjemline Y, Piette JC, Bonnet D. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol 2006;48:1682-7.
22. Eronen M, Miettinen A, Walle TK, Chan EK, Julkunen H. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block. Acta Paediatr 2004;93:803-9.
23. Smits JP, Veldkamp MW, Wilde AA. Mechanisms of inherited cardiac conduction disease. Europace 2005;7:122-37.
24. Brucato A, Franceschini F, Gasparini M et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol 1995;22:533-40.
25. Dörner T, Chaoui R, Feist E, Goldner B, Yamamoto K, Hiepe F. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. J Autoimmun 1995;8:675-84.
26. Silverman ED, Buyon J, Laxer RM et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995;100:499-505.
27. Buyon JP, Winchester RJ, Slade SG et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993;36:1263-73.
28. Julkunen H, Kurki P, Kaaja R et al. Isolated congenital heart block - Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993;36:1588-98.
29. Meilof JF, Frohn-Mulder IM, Stewart PA et al. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus 1993;2:239-46.
30. Dörner T, Feist E, Wagenmann A et al. Anti-52kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J Rheumatol 1996;23:462-8.
31. Buyon JP, Ben-Chetrit E, Karp S et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989;84:627-34.
32. Gordon P, Khamashta MA, Rosenthal E et al. Anti-52kDa Ro, anti-60kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004;31:2480-7.